Company news

Quanterix Corporation news in 2025

Quanterix Corporation's news releases, calls and decks from 2025, newest first.

View company

Quanterix Announces Landmark Nature Study Redefining Alzheimer’s Disease Neuropathology Prevalence

December 22, 2025

Quanterix Announces Board and Leadership Changes to Support Next Stage of Growth

November 20, 2025

Quanterix Announces Landmark Study Demonstrating Dual GFAP/NfL Blood Test Approach for Personalized Multiple Sclerosis Monitoring

November 17, 2025

Quanterix Releases Financial Results for the Third Quarter of 2025

November 10, 2025

Quanterix To Report Third Quarter 2025 Financial Results on November 10, 2025

November 3, 2025

Quanterix Accelerator Laboratory Awarded Rigorous New York State Clinical Laboratory Permit

August 21, 2025

Quanterix to Present at the Canaccord Genuity 45th Annual Growth Conference

August 11, 2025

Quanterix Releases Financial Results for the Second Quarter of 2025

August 7, 2025

Quanterix To Report Second Quarter 2025 Financial Results on August 7, 2025

August 4, 2025

Quanterix Announces Cooperation Agreement with Kent Lake Capital

August 4, 2025

Quanterix Launches Novel p-Tau 205 and p-Tau 212 Assays to Advance Alzheimer's Research at AAIC

July 28, 2025

Quanterix Completes Acquisition of Akoya Biosciences, Creating the First Integrated Platform Capable of Measuring Biomarkers Across the Blood and Tissue Continuum

July 8, 2025

Quanterix Expands Reach with IVD and Large Reference Labs

June 23, 2025

Quanterix to Present at Goldman Sachs Global Healthcare Conference

June 6, 2025

Quanterix Releases Financial Results for the First Quarter of 2025

May 12, 2025

Quanterix To Report First Quarter 2025 Financial Results on May 12, 2025

May 5, 2025

Kent Lake Issues Statement on Quanterix’s Blatant Disregard for Will of Shareholders

April 30, 2025

Quanterix and Akoya Biosciences Announce Amended Merger Agreement

April 29, 2025

Quanterix Showcases Innovation Powered by Simoa® at AD/PD with Customer Research and New Dried Blood Spot Extraction Kit

April 1, 2025

Quanterix Releases Financial Results for the Fourth Quarter of 2024

March 17, 2025

Quanterix To Report Fourth Quarter and Full Year 2024 Financial Results on March 17, 2025

March 13, 2025

Quanterix Highlights Compelling Benefits of Akoya Biosciences Acquisition

March 3, 2025

Calls in 2025

Decks in 2025